Skip to main content
Clinical Trials/IRCT20230703058652N1
IRCT20230703058652N1RecruitingPhase 3

The effects of intraarticular vancomycin in preventing infection in patients undergoing hip hemiarthroplasty

Ahvaz University of Medical Sciences0 sites48 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
50 years to no limit (—)
Sex
All

Inclusion Criteria

  • Femoral neck fracture patients candidates for primary hip hemiarthroplasty
  • Age over 50 years
  • Patient consent to participate in the study

Exclusion Criteria

  • patients that are candidate for total hip arthroplasty
  • known allergy to vancomycin
  • patients with renal disease and those have high creatinin level
  • active infection, local or systemic
  • patients with skin disorders in surgery site
  • patients undergo revision surgery
  • Auditory disorders
  • immunocompromization

Investigators

Similar Trials

intraarticular vancomycin in hip... | Clinical Trial